Filing Details

Accession Number:
0001367644-20-000033
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-08 20:19:35
Reporting Period:
2020-04-06
Accepted Time:
2020-04-08 20:19:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1778426 Sean Kirk 400 Professional Drive, Suite 400
Gaithersburg MD 20879
Evp, Manufacturing & Tech Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-04-06 5,666 $60.00 12,571 No 4 S Direct
Common Stock Acquisiton 2020-04-06 3,135 $30.86 15,706 No 4 M Direct
Common Stock Disposition 2020-04-06 3,135 $60.00 12,571 No 4 S Direct
Common Stock Acquisiton 2020-04-06 7,293 $30.63 19,864 No 4 M Direct
Common Stock Disposition 2020-04-06 7,293 $60.00 12,571 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Employee Stock Options (Right To Buy) Employee Stock Options (Right to Buy) Disposition 2020-04-06 3,135 $60.00 3,135 $30.86
Employee Stock Options (Right To Buy) Employee Stock Options (Right to Buy) Disposition 2020-04-06 7,293 $60.00 7,293 $30.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,805 2021-02-28 No 4 S Direct
31,512 2022-02-27 No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirk.
  2. Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
  3. The options vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company.